Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...
Everyday Health on MSN
How to find and evaluate clinical trials for metastatic bladder cancer
Learn how to find a research study for stage 4 bladder cancer and how to decide if one is right for you.
The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Hosted on MSN
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery
A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it surgically removed.
For patients with high-risk, non-muscle-invasive bladder cancer, the oncolytic immunotherapy cretostimogene grenadenorepvec shows a clinically meaningful antitumor response, according to a study ...
NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
Add Yahoo as a preferred source to see more of our stories on Google. There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. Photo ...
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the expansion of its global registration-enabling clinical ...
A new immunotherapy helped many patients with an aggressive form of bladder cancer avoid surgical removal of their bladders ...
Alpha1H demonstrated significant tumor reduction and immune activation in non-muscle invasive bladder cancer, with an 80% response rate and 59% average tumor shrinkage in high-dose groups. The drug ...
Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results